Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus Thalidomide

Principles and Practice of Endocrinology and Metabolism.

1991 • 801 citations

An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer

2008 • 438 citations

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

2005 • 312 citations

Measurement of the Systemic Inflammatory Response Predicts Cancer-Specific and Non-Cancer Survival in Patients With Cancer

2001 • 239 citations

Megestrol acetate for treatment of anorexia-cachexia syndrome

2005 • 206 citations

Managing Cancer-Related Anorexia/Cachexia

2001 • 172 citations

Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.

1998 • 158 citations

Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome

2011 • 130 citations

A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life

2011 • 130 citations

Thalidomide as a novel therapeutic agent: new uses for an old product

2005 • 124 citations

Cytokine Involvement in Cancer Anorexia/ Cachexia: Role of Megestrol Acetate and Medroxyprogesterone Acetate on Cytokine Downregulation and Improvement of Clinical Symptoms

1998 • 109 citations

Thalidomide for managing cancer cachexia

2012 • 96 citations

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

1998 • 90 citations

Counteracting Inflammation: A Promising Therapy in Cachexia

2012 • 66 citations

Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks

2012 • 64 citations

The physiological action of progesterone and the pharmacological effects of progestogens--a short review.

1978 • 61 citations

Medroxyprogesterone acetate in the management of cancer cachexia

2009 • 56 citations

Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia

2012 • 52 citations

Megestrol acetate in cachexia and anorexia

2006 • 51 citations

The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic Cancer

2010 • 51 citations

Treatment of cachexia in oncology

2010 • 49 citations

A Phase II Dose Titration Study of Thalidomide for Cancer-Associated Anorexia

2011 • 43 citations

Health-related quality of life and needs of care and support of adult Tanzanians with cancer: a mixed-methods study

2012 • 42 citations

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.

2003 • 35 citations

Prognostication in Advanced Cancer: A Study Examining an Inflammation-Based Score

2012 • 32 citations

Prominent Chemopreventive and Chemoenhancing Effects for Resveratrol: Unraveling Molecular Targets and the Role of C-Reactive Protein

2010 • 24 citations

Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

2009 • 23 citations

Fatigue in gynaecological cancer patients: a pilot study

2005 • 18 citations

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

2009 • 13 citations

Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/ cachexia and emesis by peripheral blood mononuclear cells of cancer patients

1997 • 12 citations

[The relevance of body composition in cancer patients: what is the evidence?].

2011 • 9 citations